129 related articles for article (PubMed ID: 17213726)
1. A new chemosensitivity assay for ascites tumor cells using a thermoreversible gelation polymer as a culture medium and the observed clinical responses.
Isogai A; Nagaya M; Matsuoka H; Watanabe T; Tsukikawa S; Kubota S
Eur Surg Res; 2007; 39(1):41-50. PubMed ID: 17213726
[TBL] [Abstract][Full Text] [Related]
2. [Repeated intraperitoneal injection of low-dose CDDP for gastric cancer with ascites owing to peritonitis carcinomatosa].
Nakagawa M; Ninomiya M; Fujita I; Matsubara M; Okamoto Y; Kawamoto H; Araki Y; Inoue J; Sasaki H; Takakura N
Gan To Kagaku Ryoho; 2002 Nov; 29(12):2346-9. PubMed ID: 12484071
[TBL] [Abstract][Full Text] [Related]
3. [A case of advanced gastric cancer with peritonitis carcinomatosa resected with intraperitoneal chemotherapy based on chemosensitivity test with ascites].
Nakamura T; Shimada K; Okubo Y; Tanaka S; Tanabe S; Yoshida M; Doi K; Uchinami M; Horiuchi T; Tanaka K
Gan To Kagaku Ryoho; 2004 Sep; 31(9):1423-6. PubMed ID: 15446570
[TBL] [Abstract][Full Text] [Related]
4. Clinical applications of the histoculture drug response assay.
Furukawa T; Kubota T; Hoffman RM
Clin Cancer Res; 1995 Mar; 1(3):305-11. PubMed ID: 9815986
[TBL] [Abstract][Full Text] [Related]
5. [Effects of intraperitoneal injection of low-dose CDDP on 3 patients with ascites owing to peritonitis carcinomatosa of gastric and colorectal carcinoma].
Kitani K; Morimoto T; Shibata N; Amano K; Nakahira S; Morita S; Tanaka T; Nomura T; Okuda H
Gan To Kagaku Ryoho; 2001 Oct; 28(11):1666-8. PubMed ID: 11708004
[TBL] [Abstract][Full Text] [Related]
6. [Effect of cisplatin (CDDP) against peritonitis carcinomatosa in nude mice inoculated intraperitoneally with human gastric cancer].
Takao S; Nomura H; Aikou T; Maenohara S; Saihara T; Kajisa T; Nishi M
Gan To Kagaku Ryoho; 1985 Aug; 12(8):1638-43. PubMed ID: 3896155
[TBL] [Abstract][Full Text] [Related]
7. Clinical trials with intraperitoneal cisplatin microspheres for malignant ascites--a pilot study.
Hagiwara A; Takahashi T; Sawai K; Sakakura C; Tsujimoto H; Osaki K; Sakakibara T; Ohyama T; Ohgaki M; Muranishi S
Anticancer Drug Des; 1993 Dec; 8(6):463-70. PubMed ID: 8286013
[TBL] [Abstract][Full Text] [Related]
8. [Treatment of cancer ascites by combined intraperitoneal administration of low-dose CDDP and reinfusion of ultra-filtrated and concentrated ascitic fluid in patients].
Takahashi Y; Imai H; Ikawa A; Yasuda K; Kawai M; Yamamori T; Furuichi N; Misawa K; Ohashi H
Gan To Kagaku Ryoho; 1999 Oct; 26(12):1820-4. PubMed ID: 10560403
[TBL] [Abstract][Full Text] [Related]
9. Oxaliplatin in treatment of the cisplatin-resistant MKN45 cell line of gastric cancer.
Tozawa K; Oshima T; Kobayashi T; Yamamoto N; Hayashi C; Matsumoto T; Miwa H
Anticancer Res; 2008; 28(4B):2087-92. PubMed ID: 18751380
[TBL] [Abstract][Full Text] [Related]
10. Biweekly oxaliplatin, fluorouracil and leucovorin versus cisplatin, fluorouracil and leucovorin in patients with advanced gastric cancer.
Popov I; Radosevic-Jelic L; Jezdic S; Milovic M; Borojevic N; Stojanovic S; Stankovic V; Josifovski T; Kezic I
J BUON; 2008; 13(4):505-11. PubMed ID: 19145671
[TBL] [Abstract][Full Text] [Related]
11. Experimental and clinical evaluation of cisplatin-containing microspheres as intraperitoneal chemotherapy for ovarian cancer.
Sugiyama T; Kumagai S; Nishida T; Ushijima K; Matsuo T; Yakushiji M; Hyon SH; Ikada Y
Anticancer Res; 1998; 18(4B):2837-42. PubMed ID: 9713471
[TBL] [Abstract][Full Text] [Related]
12. [Clinical efficacy of two-route chemotherapy with CDDP and STS in patients with peritonitis carcinomatosa].
Kuwahara A; Saito T; Nakashima K; Shigemitsu Y; Hirao E; Kobayashi M
Gan To Kagaku Ryoho; 1989 Aug; 16(8 Pt 2):2752-5. PubMed ID: 2782887
[TBL] [Abstract][Full Text] [Related]
13. A prospective randomized controlled trial of tumour chemosensitivity assay directed chemotherapy versus physician's choice in patients with recurrent platinum-resistant ovarian cancer.
Cree IA; Kurbacher CM; Lamont A; Hindley AC; Love S;
Anticancer Drugs; 2007 Oct; 18(9):1093-101. PubMed ID: 17704660
[TBL] [Abstract][Full Text] [Related]
14. AKT1 amplification regulates cisplatin resistance in human lung cancer cells through the mammalian target of rapamycin/p70S6K1 pathway.
Liu LZ; Zhou XD; Qian G; Shi X; Fang J; Jiang BH
Cancer Res; 2007 Jul; 67(13):6325-32. PubMed ID: 17616691
[TBL] [Abstract][Full Text] [Related]
15. [Pharmacokinetic study of intraperitoneal cisplatin chemotherapy for gastric cancer as an adjuvant setting].
Kochi M; Fujii M; Takano S; Kato Y; Kawakami T; Kanamori N; Iwai S; Tanaka T
Gan To Kagaku Ryoho; 1995 Sep; 22(11):1535-7. PubMed ID: 7574752
[TBL] [Abstract][Full Text] [Related]
16. [Intraperitoneal high-dose cisplatinum chemotherapy (CDDP-ip) in patients with carcinomatous peritonitis].
Noda T; Oku M; Kiyozuka Y; Ninomiya Y; Hino K; Okamura Y; Maruyama M; Ichijo M
Gan To Kagaku Ryoho; 1987 Apr; 14(4):1025-32. PubMed ID: 3566301
[TBL] [Abstract][Full Text] [Related]
17. Cisplatin plus weekly vinorelbine versus cisplatin plus vinorelbine on days 1 and 8 in advanced non-small cell lung cancer: a prospective randomized phase III trial of the G.O.I.M. (Gruppo Oncologico Italia Meridionale).
Gebbia V; Galetta D; Lorusso V; Caruso M; Verderame F; Pezzella G; Borsellino N; Durini E; Valenza R; Agostara B; Colucci G;
Lung Cancer; 2008 Sep; 61(3):369-77. PubMed ID: 18308419
[TBL] [Abstract][Full Text] [Related]
18. [Pharmacokinetics following intraperitoneal infusion of cisplatinum with and without sodium thiosulfate rescue in carcinomatous peritonitis in advanced gastric cancers].
Namatame K; Kou Y; Nakayoshi A
Gan To Kagaku Ryoho; 1991 Aug; 18(11):1784-9. PubMed ID: 1877818
[TBL] [Abstract][Full Text] [Related]
19. [Effects of repeated intraperitoneal CDDP chemotherapy for the prevention of T3 and T4 gastric cancer].
Yano S; Ninomiya M; Sasaki H; Umeoka T; Harano M; Aoki H; Onoda T; Shiozaki S; Ohno S; Higaki K; Takakura N
Gan To Kagaku Ryoho; 2004 Oct; 31(11):1720-2. PubMed ID: 15553694
[TBL] [Abstract][Full Text] [Related]
20. Weekly infusional high-dose 5-fluorouracil and leucovorin and biweekly cisplatin: a convenient treatment option in advanced gastric cancer.
Kundel Y; Purim O; Figer A; Stemmer SM; Tichler T; Sulkes J; Sulkes A; Brenner B
Med Sci Monit; 2008 Apr; 14(4):CR190-5. PubMed ID: 18376346
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
